药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Heptabarbital
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lenvatinib.
Heptabarbital
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lenvatinib.
Heptabarbital
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Lenvatinib.
Heptabarbital
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Lenvatinib.
Heptabarbital
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Lenvatinib.
Heptabarbital
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Lenvatinib.
Heptabarbital
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Lenvatinib.
Heptabarbital
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Lenvatinib.
Heptabarbital
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Lenvatinib.
Heptabarbital
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Lenvatinib.
Heptabarbital
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Lenvatinib.
Heptabarbital
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Lenvatinib.
Heptabarbital
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Lenvatinib.
Heptabarbital
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Lenvatinib.
Heptabarbital
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Lenvatinib.
Heptabarbital
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Lenvatinib.
Heptabarbital
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Lenvatinib.
Heptabarbital
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Lenvatinib.
Heptabarbital
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Lenvatinib.
Heptabarbital
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Lenvatinib.